Anaemia, prenatal iron use, and risk of adverse pregnancy outcomes: systematic review and meta-analysis
BA Haider, I Olofin, M Wang, D Spiegelman, M Ezzati… - Bmj, 2013 - bmj.com
Objectives To summarise evidence on the associations of maternal anaemia and prenatal
iron use with maternal haematological and adverse pregnancy outcomes; and to evaluate …
iron use with maternal haematological and adverse pregnancy outcomes; and to evaluate …
[HTML][HTML] Paclitaxel plus bevacizumab versus paclitaxel alone for metastatic breast cancer
K Miller, M Wang, J Gralow, M Dickler… - New England journal …, 2007 - Mass Medical Soc
Background In an open-label, randomized, phase 3 trial, we compared the efficacy and
safety of paclitaxel with that of paclitaxel plus bevacizumab, a monoclonal antibody against …
safety of paclitaxel with that of paclitaxel plus bevacizumab, a monoclonal antibody against …
[HTML][HTML] Alternative dietary indices both strongly predict risk of chronic disease
Abstract The Healthy Eating Index-2005 (HEI-2005) measures adherence to the 2005
Dietary Guidelines for Americans, but the association between the HEI-2005 and risk of …
Dietary Guidelines for Americans, but the association between the HEI-2005 and risk of …
[HTML][HTML] Prognostic value of tumor-infiltrating lymphocytes in triple-negative breast cancers from two phase III randomized adjuvant breast cancer trials: ECOG 2197 …
Purpose Recent studies suggest that tumor-infiltrating lymphocytes (TILs) are associated
with disease-free (DFS) and overall survival (OS) in operable triple-negative breast cancer …
with disease-free (DFS) and overall survival (OS) in operable triple-negative breast cancer …
[HTML][HTML] Weekly paclitaxel in the adjuvant treatment of breast cancer
JA Sparano, M Wang, S Martino, V Jones… - … England Journal of …, 2008 - Mass Medical Soc
Background We compared the efficacy of two different taxanes, docetaxel and paclitaxel,
given either weekly or every 3 weeks, in the adjuvant treatment of breast cancer. Methods …
given either weekly or every 3 weeks, in the adjuvant treatment of breast cancer. Methods …
Associations between Per-and polyfluoroalkyl substances exposures and blood lipid levels among adults—a meta-analysis
Background: Associations between per-and polyfluoroalkyl substances (PFAS) and blood
lipid levels in humans were mixed. Objectives: The objective of this meta-analysis was to …
lipid levels in humans were mixed. Objectives: The objective of this meta-analysis was to …
[HTML][HTML] Association of vascular endothelial growth factor and vascular endothelial growth factor receptor-2 genetic polymorphisms with outcome in a trial of paclitaxel …
BP Schneider, M Wang, M Radovich… - Journal of Clinical …, 2008 - ncbi.nlm.nih.gov
Purpose No biomarkers have been identified to predict outcome with the use of an
antiangiogenesis agent for cancer. Vascular endothelial growth factor (VEGF) genetic …
antiangiogenesis agent for cancer. Vascular endothelial growth factor (VEGF) genetic …
[HTML][HTML] 24-hour urinary sodium and potassium excretion and cardiovascular risk
Background The relation between sodium intake and cardiovascular disease remains
controversial, owing in part to inaccurate assessment of sodium intake. Assessing 24-hour …
controversial, owing in part to inaccurate assessment of sodium intake. Assessing 24-hour …
Cardiometabolic outcomes and mortality in medically treated primary aldosteronism: a retrospective cohort study
GL Hundemer, GC Curhan, N Yozamp… - The lancet Diabetes & …, 2018 - thelancet.com
Background Mineralocorticoid receptor (MR) antagonists are the recommended medical
therapy for primary aldosteronism. Whether this recommendation effectively reduces …
therapy for primary aldosteronism. Whether this recommendation effectively reduces …
Healthy lifestyle and life expectancy free of cancer, cardiovascular disease, and type 2 diabetes: prospective cohort study
Objective To examine how a healthy lifestyle is related to life expectancy that is free from
major chronic diseases. Design Prospective cohort study. Setting and participants The …
major chronic diseases. Design Prospective cohort study. Setting and participants The …